Description
Co-Prenesa Tablets 2 mg/0.625 mg
Composition
Active ingredients: Perindopril tert-butylamine, Indapamide
Mechanism of Action
Perindopril tert-butylamine, an ACE inhibitor, inhibits the angiotensin-converting enzyme, leading to vasodilation and reduced blood pressure. Indapamide, a thiazide-like diuretic, promotes diuresis and helps lower blood pressure through its effects on electrolyte balance.
Pharmacological Properties
Co-Prenesa tablets combine the antihypertensive effects of perindopril and indapamide to effectively manage hypertension by lowering blood pressure.
Indications for Use
Co-Prenesa tablets are indicated for the treatment of hypertension to lower blood pressure levels in patients.
Contraindications
Do not use Co-Prenesa tablets if you:
- Are allergic to any of the ingredients
- Have a history of angioedema related to previous ACE inhibitor therapy
- Are pregnant or breastfeeding
Side Effects
Common side effects may include dizziness, headache, or cough. Consult your healthcare provider if any side effects persist or worsen.
Usage Instructions
Take one Co-Prenesa tablet daily, orally with or without food, or as prescribed by your healthcare professional. Do not exceed the recommended dosage.
Benefits Compared to Analogues
Co-Prenesa has demonstrated comparable efficacy to similar drugs with a lower risk of adverse effects such as hypokalemia. Consult your healthcare provider for personalized recommendations based on your medical history and condition.
Suitable Patient Groups
Co-Prenesa tablets are suitable for adult patients with hypertension. Consult a healthcare provider for guidance on use in specific patient populations such as children or the elderly.
Storage and Shelf Life
Store Co-Prenesa tablets at room temperature, away from moisture and heat. Keep out of reach of children. Check the expiration date on the packaging and do not use expired medication.
Packaging Description
Co-Prenesa tablets are available in a package containing 30 tablets.
Clinical Evidence and Proven Effectiveness
Co-Prenesa tablets have shown efficacy in numerous clinical trials for the treatment of hypertension. A study published in the Journal of Clinical Hypertension demonstrated that the combination of perindopril and indapamide led to a significant reduction in blood pressure levels compared to placebo.
